White House, Big Pharma, We Have a Problem

In June, I wrote a story that raised big questions about the value of the government’s $80 billion deal with Big Pharma, and wondered if the deal came with the trade-off of killing legislation that would enable the government to negotiate directly with pharmaceutical companies for lower prices. Such a trade-off would be indefensible. That [...]